{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T20:19:12Z","timestamp":1784146752235,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"crossref","award":["CMRPG8F1241"],"award-info":[{"award-number":["CMRPG8F1241"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"crossref","award":["CMRPG8F1242"],"award-info":[{"award-number":["CMRPG8F1242"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.humpath.2018.05.026","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T04:47:15Z","timestamp":1528260435000},"page":"145-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression"],"prefix":"10.1016","volume":"80","author":[{"given":"Hui-Shan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Kai","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huey-Ling","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2018.05.026_bb0005","series-title":"WHO classification of tumours of hamatopoietic and lymphoid tissue","first-page":"197","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.humpath.2018.05.026_bb0010","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2018.05.026_bb0015","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2018.05.026_bb0020","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from \u03b3\u03b4-T or NK cells","volume":"6","author":"K\u00fc\u00e7\u00fck","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2018.05.026_bb0025","first-page":"83","article-title":"Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers","volume":"10","author":"Nichols","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.humpath.2018.05.026_bb0030","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/1947601911408889","article-title":"Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis","volume":"2","author":"Rivlin","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.humpath.2018.05.026_bb0035","article-title":"TP53 mutation predicts the poor prognosis of non-Hodgkin lymphomas: evidence from a meta-analysis","volume":"12","author":"Xu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2018.05.026_bb0040","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/hupa.2001.21569","article-title":"Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations","volume":"32","author":"Petit","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2018.05.026_bb0045","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1182\/blood.V80.12.3205.3205","article-title":"Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia\/lymphoma shows frequent p53 mutations","volume":"80","author":"Cesarman","year":"1992","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.humpath.2018.05.026_bb0050","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0002-9440(10)63061-1","article-title":"p53 mutations in nasal natural killer\/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease","volume":"159","author":"Quintanilla-Martinez","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2018.05.026_bb0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/labinvest.3780055","article-title":"Mutations of the p53 gene in nasal NK\/T-cell lymphoma","volume":"80","author":"Li","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.humpath.2018.05.026_bb0060","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1600-0560.1999.tb01860.x","article-title":"p53 tumor suppressor gene mutations in transformed cutaneous T-cell lymphoma: a study of 12 cases","volume":"26","author":"Marrogi","year":"1999","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2018.05.026_bb0065","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.humpath.2018.05.026_bb0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12864-016-3425-4","article-title":"Detecting very low allele fraction variants using targeted DNA sequencing and a novel molecular barcode-aware variant caller","volume":"18","author":"Xu","year":"2017","journal-title":"BMC Genomics"},{"key":"10.1016\/j.humpath.2018.05.026_bb0075","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/bioinformatics\/btq330","article-title":"Deriving the consequences of genomic variants with the Ensembl API and SNP effect predictor","volume":"26","author":"McLaren","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.humpath.2018.05.026_bb0080","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2018.05.026_bb0085","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","article-title":"Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes","volume":"132","author":"Deleeuw","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2018.05.026_bb0090","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.humpath.2018.05.026_bb0095","article-title":"Clinical relevance of gain of function mutations of p53 in high-grade serous ovarian carcinoma","volume":"8","author":"Kang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2018.05.026_bb0100","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.onc.1202314","article-title":"Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy","volume":"18","author":"Blandino","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2018.05.026_bb0105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00001813-200007000-00002","article-title":"Does p53 status influence tumor response to anticancer therapies?","volume":"11","author":"Pirollo","year":"2000","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.humpath.2018.05.026_bb0110","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10495-009-0330-1","article-title":"Targeting p53 for enhanced radio- and chemo-sensitivity","volume":"14","author":"Lu","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.humpath.2018.05.026_bb0115","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/jcb.25592","article-title":"TP53 mutations in head and neck squamous cell carcinoma and their impact on disease progression and treatment response","volume":"117","author":"Zhou","year":"2016","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.humpath.2018.05.026_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/srep17879","article-title":"TP53 mutational analysis enhances the prognostic accuracy of IHC4 and PAM50 assays","volume":"5","author":"Lin","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.humpath.2018.05.026_bb0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/gcc.2870140113","article-title":"TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains","volume":"14","author":"B\u00f8rresen","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2018.05.026_bb0130","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1078-0432.CCR-05-1029","article-title":"The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer","volume":"12","author":"Olivier","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2018.05.026_bb0135","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1073\/pnas.1510043112","article-title":"Amino-terminal p53 mutations lead to expression of apoptosis proficient p47 and prognosticate better survival, but predispose to tumorigenesis","volume":"112","author":"Phang","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2018.05.026_bb0140","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1158\/1078-0432.CCR-04-1547","article-title":"Evaluation of the combined effect of p53 codon 72 polymorphism and hotspot mutations in response to anticancer drugs","volume":"11","author":"Vikhanskaya","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2018.05.026_bb0145","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1158\/1078-0432.CCR-08-1719","article-title":"Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma","volume":"15","author":"Katkoori","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2018.05.026_bb0150","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1038\/sj.onc.1207428","article-title":"Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo","volume":"23","author":"Sullivan","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2018.05.026_bb0155","first-page":"771","article-title":"Prognostic impact of p53 Pro72 homozygous genotype in non-small cell lung cancer patients","volume":"19","author":"Boldrini","year":"2008","journal-title":"Oncol Rep"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718301941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718301941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T23:58:49Z","timestamp":1571443129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817718301941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":31,"alternative-id":["S0046817718301941"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2018.05.026","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2018.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}